Old Mission Capital’s Omnicell OMCL Stock Holding History

Old Mission Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,250	Closed	-$2.87M	–	1231
2022 Q2	$2.87M	Buy	+25,250	New	+$2.9M	0.08%	231

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Old Mission Capital's OMCL Position: Q3 2022 in Review

Old Mission Capital sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 25,250 shares — an estimated $2.87M sold.

Old Mission Capital first reported a position in OMCL in Q2 2022 and held it in 1 quarter. The position peaked at $2.87M in Q2 2022. 373 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

Old Mission Capital reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
Old Mission Capital sold 25,250 Omnicell shares in Q3 2022, an estimated $2.87M.
Old Mission Capital first reported a position in Omnicell in Q2 2022 and held it in 1 quarter.
Old Mission Capital's Omnicell position peaked at $2.87M in Q2 2022.
373 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.